Pediatric autologous peripheral blood stem cell collection without heparin using a highly concentrated sodium citrate anticoagulant: A retrospective comparison with standard ACD ‐A
Transfusion · 2026
DOI: 10.1111/trf.70102 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Transfusion, 2026. Verfasst von Keiko Fujii und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Okayama University Hospital, Okayama, Japan. Hauptthemen laut MEDLINE: Anticoagulants, Sodium Citrate, Peripheral Blood Stem Cells, Citrates. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Heparin combined with sodium citrate has been used in leukocytapheresis for pediatric patients. Since 2022, we have performed leukocytapheresis using a highly concentrated sodium citrate solution (HSC, 5.32%) instead of acid citrate dextrose solution A (ACD‐A). We conducted this study to determine whether HSC use reduces run time and the total amount of anticoagulant solution in children. Study Design and Methods We retrospectively analyzed data from consecutive autologous peripheral blood stem cell harvests (auto‐PBSCHs) between June 2012 and May 2025, including patient characteristics, mobilization methods, protocol used, anticoagulant type, run time, total anticoagulant solution volume, and collection efficiency.
Results
Auto‐PBSCH was performed using the mononuclear cell collection (MNC) protocol in 28 procedures and the continuous MNC protocol in 20 procedures. ACD‐A was used in 35 procedures and HSC in 13. The run time was significantly shorter (204 [range, 117–302] vs. 157 min [range, 103–227], p = .02) in the HSC group and also confirmed in multivariable regression analysis (coefficient, −55.6; 95% confidence interval, −106.2 to −5.04; p = .03). In a subgroup analysis of cMNC procedures, CD34 + collection efficiency showed a strong negative correlation with the proportion of run time devoted to establishing the initial interface ( r = −.73, p = .0003).
Conclusion
Delays in establishing the initial interface can reduce the duration of the effective MNC collection phase and may negatively affect collection efficiency. Careful attention to the initial interface phase is therefore warranted when using HSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Okayama University Hospital, Okayama, Japan.
- Division of Clinical Laboratory, Okayama University Hospital, Okayama, Japan.
- Department of Pediatrics, Okayama University Hospital, Okayama, Japan.
- Division of Transfusion and Cell Therapy, Okayama University Hospital, Okayama, Japan.
- Department of General Medicine, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
ORCID-Profile: Keiko Fujii, Wataru Kitamura, Fumio Otsuka, Nobuharu Fujii
Zitieren
APA
Fujii, K., Kitamura, W., Washio, K., Ikeuchi, K., Shimono, J., Murakami, H., Otsuka, F., Maeda, Y., & Fujii, N. (2026). Pediatric autologous peripheral blood stem cell collection without heparin using a highly concentrated sodium citrate anticoagulant: A retrospective comparison with standard ACD ‐A. Transfusion. https://doi.org/10.1111/trf.70102
Vancouver
Fujii K, Kitamura W, Washio K, Ikeuchi K, Shimono J, Murakami H, et al. Pediatric autologous peripheral blood stem cell collection without heparin using a highly concentrated sodium citrate anticoagulant: A retrospective comparison with standard ACD ‐A. Transfusion. 2026. doi:10.1111/trf.70102
BibTeX
@article{Fujii2026,
author = {Fujii, Keiko and Kitamura, Wataru and Washio, Kana and Ikeuchi, Kazuhiro and Shimono, Joji and Murakami, Hiroyuki and Otsuka, Fumio and Maeda, Yoshinobu and Fujii, Nobuharu},
title = {Pediatric autologous peripheral blood stem cell collection without heparin using a highly concentrated sodium citrate anticoagulant: A retrospective comparison with standard ACD ‐A},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70102}
}
EUVIMED